Teleflex Incorporated TFX
156.30 USD +1.54 (+1.00%)
As ofNov 16, 2026, 12:28 PM EST
154.63 Day range 156.38
100.18 52-week range 156.75
- YTD
- +28.07%
- 1 year
- +46.07%
News
seekingalpha.com Teleflex: The Market Is Pricing The Transition, Not The Company Coming Out Of It Teleflex is undergoing a portfolio overhaul, with future earnings driven by cost cuts, deleveraging, and share buybacks rather than top-line growth. TFX's adjusted gross margin reached 66.8% in Q3;…
businesswire.com Teleflex to Present at the Jefferies Global Healthcare Conference in London WAYNE, Pa.--(BUSINESS WIRE)--Management of Teleflex Incorporated (NYSE: TFX) is scheduled to speak at the Jefferies Global Healthcare Conference in London on Wednesday, November 18, 2026, at 12:00…benzinga.com Truist Securities Maintains Hold on Teleflex, Raises Price Target to $167 Truist Securities analyst Ravi Misra maintains Teleflex (NYSE:TFX) with a Hold and raises the price target from $142 to $167.
benzinga.com RBC Capital Maintains Outperform on Teleflex, Raises Price Target to $175 RBC Capital analyst Kendall Au maintains Teleflex (NYSE:TFX) with a Outperform and raises the price target from $155 to $175.
benzinga.com Wells Fargo Maintains Equal-Weight on Teleflex, Raises Price Target to $167 Wells Fargo analyst Larry Biegelsen maintains Teleflex (NYSE:TFX) with a Equal-Weight and raises the price target from $138 to $167.
benzinga.com Teleflex Q3 2026 Earnings Call Transcript Teleflex (NYSE:TFX) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…benzinga.com Teleflex Raises FY2026 Adj EPS Guidance from $6.90-$7.20 to $7.50-$7.75 vs $7.22 Est; Lowers FY2026 Sales Guidance from $2.260B-$2.280B to $2.256B-$2.276B vs $2.269B Est Teleflex (NYSE:TFX) raises FY2026 Adj EPS guidance from $6.90-$7.20 to $7.50-$7.75 vs $7.22 analyst estimate. Lowers FY2026 sales outlook from $2.260 billion-$2.280 billion to $2.256 billion-$2.276…
benzinga.com Teleflex Q3 Adj. EPS $2.63 Beats $1.90 Estimate, Sales $567.800M Beat $566.772M Estimate Teleflex (NYSE:TFX) reported quarterly earnings of $2.63 per share which beat the analyst consensus estimate of $1.90 by 38.42 percent. The company reported quarterly sales of $567.800 million which…
benzinga.com Teleflex Receives FDA Breakthrough Device Designation For Its Freesolve Resorbable Magnesium Scaffold For Percutaneous Coronary Intervention To qualify for a BDD, device technology must address an unmet clinical need and show that it has the potential to provide for more effective treatment of life-threatening diseases or irreversibly…
